Advances in Hot Melt Extrusion Technology

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".

Deadline for manuscript submissions: 30 March 2025 | Viewed by 102

Special Issue Editors


E-Mail Website
Guest Editor
Technical Operations, Cerevel Therapeutics, Cambridge, MA 02141, USA
Interests: hot melt extrusion; spray drying; continuous manufacturing; additive manufacturing; solid oral dosage forms; lipid based drug delivery systems; twin screw granulation; amorphous solid dispersions; implants; colon targeted drug delivery; gastro retentive formulations

E-Mail Website
Guest Editor
Leading Research Group, Riga Stradiņš University, LV-1007 Riga, Latvia
Interests: drug delivery and respective analytical methods; improving the solubility and bioavailability (BA) of poorly soluble drugs oral dosage forms (ODF); tailored drug release and improved customer properties of ODF; alcohol-resistant sustained-release ODF; abuse deterrent ODF; long-acting parenteral implants; hot-melt extrusion (HME); fluid-bed coating; loading of porous carriers; co-precipitation; easy-swallowing; taste-masked; delayed-, modified-release pellets & tablets; fluid-bed/pan-coating; matrix tablets; roll compaction (RC); continuous manufacturing of solid DF incl. continuous processing steps; emulsification congealing/polymerization; microfluidics; 3D-printing; compression-moulding

Special Issue Information

Dear Colleagues,

In recent years, hot melt extrusion (HME) has attracted the attention of researchers from the pharmaceutical industry and regulatory agencies due to its wide variety of applications in developing pharmaceutical medications. HME has been widely investigated in regard to improving the solubility and bioavailability of poorly soluble drug substances via amorphous solid dispersions, co-crystals, salts, co-amorphous systems, cyclodextrin complexation, solid crystal suspension, and lipid-based drug delivery systems. It is a single-step continuous manufacturing process that involves the application of thermal and mechanical shear, and it uses no solvent. Along with extrusion, the extruder is also suitable for the granulation process, referred to as twin-screw granulation (TSG). The extruder can also be coupled with an additive manufacturing process to fabricate patient-centric dosage forms. Along with the above-discussed application, the HME can also be employed for novel applications such as spheronization, co-extrusion, and injection molding. This Special Issue presents recent advancements, technical innovations, and practical applications of HME in drug formulation. Contributions exploring process optimization, material selection, characterization techniques, and clinical implications are invited, providing a comprehensive overview of HME's impact on modern pharmaceutics.

We encourage the submission of original research articles, comprehensive reviews, and case studies that explore the latest breakthroughs in HME. This Special Issue will be a vital resource for scientists, researchers, and industry professionals aiming to leverage HME for innovative pharmaceutical solutions. Join us in advancing the field by sharing your expertise and insights on this dynamic and rapidly evolving technology.

We look forward to receiving your contributions.

Dr. Dinesh Nyavanandi
Dr. Valentyn Mohylyuk
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hot melt extrusion
  • solubility enhancement
  • amorphous solid dispersion
  • additive manufacturing
  • twin screw granulation
  • continuous manufacturing
  • lipid-based drug delivery systems
  • patient-centric dosage forms
  • fused deposition modeling 3D printing
  • bioavailability

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop